Lilly insulin tops Sa**fi?s Lantus in trials; liver issue persists
 

Lilly insulin tops Sa**fi?s Lantus in trials; liver issue persists
June 6 (Reuters) - A long-acting insulin being developed by Eli Lilly and Co demonstrated greater blood sugar reduction than Sa**fi SA's top-selling Lantus in patients with type 2 diabetes, according to data from three Phase III trials presented on Saturday.http://i1.wp.com/reuters.us.feedspor...f?resize=1%2C1


http://da.feedsportal.com/r/23104144...14/rc/1/rc.img
http://da.feedsportal.com/r/23104144...14/rc/2/rc.img
http://da.feedsportal.com/r/23104144...14/rc/3/rc.img

http://da.feedsportal.com/r/23104144...3/sc/14/a2.img
http://adchoice.feedsportal.com/r/23.../sc/14/ach.imghttp://pi.feedsportal.com/r/23104144.../sc/14/a2t.imghttp://pi2.feedsportal.com/r/2310414...sc/14/a2t2.imghttp://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...2c:V_sGLiPBpWU http://feeds.feedburner.com/~ff/reut...2c:F7zBnMyn0Lo
http://feeds.feedburner.com/~r/reute...~4/NnZj79l9txo